Characterization of High-Level Cognitive Impairments in Patients With Neuropsychiatric Disorders
Recruiting · NCT07295652 · Interventional (participants receive a specific treatment) · Lead sponsor: Centre Hospitalier St Anne
View the official record on ClinicalTrials.gov →Interventions studied
What this trial is about
Neuropsychiatric disorders are extremely common, severe, and disabling conditions. In the field of psychiatry, they notably include schizophrenia, mood disorders (depressive and bipolar disorders), autism spectrum or neurodevelopmental disorders, obsessive-compulsive disorder, eating disorders, and personality disorders. In the field of neurology, one can cite neurodegenerative diseases (such as Alzheimer's disease, but also frontotemporal dementia or Parkinson's disease, which often represent frequent and challenging differential diagnoses of psychiatric disorders), focal neurological lesions (notably strokes and tumors), or epilepsy. Cognitive impairments are present in nearly all neuropsychiatric disorders and contribute significantly to disability. While impairments in working memory and attention, executive functions, and social cognition have been relatively well studied, other cognitive domains remain largely unexplored in these populations. This is particularly the case for various aspects of motivation, metacognition, conscious access, or causal (Bayesian) inference. Although these domains likely play an important role in prognosis, no consensus currently exists regarding the methods for evaluating these functions. The main objective of this study is to define a multidimensional, transdiagnostic atlas of high-level cognitive impairments-both specific and shared-across severe psychiatric disorders (notably schizophrenia, depressive disorder, bipolar disorder, autism spectrum or neurodevelopmental disorders, and obsessive-compulsive disorder) and neurological disorders (notably neurodegenerative diseases, focal neurological lesions, and epilepsy), by comparing them to healthy volunteers. The investigators also aim to investigate the progression of cognitive impairments over time, across different phases of illness (symptom stabilization or exacerbation) or therapeutic intervention, through longitudinal follow-up of patients being monitored within the recruiting center. Finally, in a more exploratory manner, the investigators aim to investigate the neural correlates of the identified cognitive impairments.
Who can take part
Inclusion criteria
- For patients:
- Aged over 18 years
- Diagnosed with a psychiatric disorder according to ICD-10 by a psychiatrist (F10-F98) or diagnosed with a neurological disorder according to ICD-10 by a neurologist (G00-G99)
- Provided written informed consent
- Affiliated with a social security scheme
- For healthy volunteers:
- Aged over 18 years
- Provided written informed consent
- Affiliated with a social security scheme
Exclusion criteria
- For healthy volunteers:
- Current diagnosis of a psychiatric disorder according to ICD-10 (F20-F98) or current prescription of a psychotropic medication, or diagnosis of a neurological disorder according to ICD-10 (G00-G99)
- History of depression (F32)
- Substance use disorder (excluding tobacco)
- Neurological history (e.g., stroke, coma, epilepsy, neuroinflammatory or neurodegenerative disease) or identified cognitive disorder
- Inability to complete cognitive testing (e.g., due to motor or sensory impairment)
- For participants undergoing MRI (without contrast agent):
- Presence of MRI contraindications: non-MRI-compatible pacemaker, heart valve, implant, or metallic foreign body
- Pregnancy at the time of MRI
Where it is running
3 locations listed.
- Departement of Adult Psychiatry, GH Pitié Salpétrière - Paris, France
- Groupe hospitalo-universitaire Paris Psychiatrie et Neurosciences - Paris, France
- Hôpital Fondation Adolphe de Rothschild - Paris, France